|
⚲
|
| OrbiMed Advisors LLC
✚
|
|
|---|---|
| CRD # | 118608 |
| SEC # | 801-61046 |
| CIK # | 0001491569, 0001055951 |
| AUM | $18.3 BB (2023-03-29) |
| Employees | 106 (75% Investors, 0% Brokers) |
| Phone | 212-739-6400 |
| Address | 601 Lexington Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] [Facebook] |
| Total AUM ($BB) |
|---|
| CIK | Period |
|---|---|
| 0001491569 0001055951 | |
| / | |
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| Boston Scientific Corp | 53.6 | 0.2 | |
| Humana Inc | 58.5 | 0.2 | |
| Bristol Myers Squibb Co | 167.6 | 0.2 | |
| Intuitive Surgical Inc | 72.5 | 0.2 | |
| BioMarin Pharmaceutical Inc | 15.4 | 0.2 | |
| Theseus Pharmaceuticals Inc | 0.2 | 0.2 | |
| Biogen IDEC Inc | 29.7 | 0.1 | |
| UnitedHealth Group Inc | 477.0 | 0.1 | |
| Avi Biopharma Inc | 6.5 | 0.1 | |
| Springworks Therapeutics Inc | 1.3 | 0.1 | |
| Stryker Corp | 74.8 | 0.1 | |
| Edgewise Therapeutics Inc | 0.4 | 0.1 | |
| Evolent Health Inc | 2.8 | 0.1 | |
| Terns Pharmaceuticals Inc | 0.1 | 0.1 | |
| Verona Pharma PLC | 0.3 | 0.1 | |
| Thermo Fisher Scientific Inc | 209.7 | 0.1 | |
| Baxter International Inc | 32.9 | 0.1 | |
| ISIS Pharmaceuticals Inc | 5.4 | 0.1 | |
| Olivia Ventures Inc | 0.3 | 0.1 | |
| Tenet Healthcare Corp | 6.0 | 0.1 | |
| Keros Therapeutics Inc | 0.6 | 0.1 | |
| Lilly Eli & Co | 301.8 | 0.1 | |
| Crinetics Pharmaceuticals Inc | 0.9 | 0.1 | |
| Apellis Pharmaceuticals Inc | 4.7 | 0.1 | |
| Si-Bone Inc | 0.5 | 0.1 | |
| Prelude Therapeutics Inc | 0.2 | 0.1 | |
| Vertex Pharmaceuticals Inc / Ma | 70.6 | 0.1 | |
| Natera Inc | 3.6 | 0.1 | |
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| PE | OrbiMed Royalty & Credit Opportunities IV Offshore LP | [2023-02-28] | 344.5 | 408.2 |
| HF | OrbiMed Partners SPV Ltd | 2022-11-14 | 48.1 | |
| Other | OrbiMed Asia Partners V LP | [2022-08-03] | 651.9 | 497.4 |
| Other | OrbiMed Private Investments IX LP | [2022-08-03] | 0.0 | 1,799.6 |
| PE | OrbiMed Royalty & Credit Opportunities IV LP | [2022-08-03] | 1,153.1 | 1,376.4 |
| Other | OrbiMed Private Investments VIII LP | [2020-11-25] | 0.0 | 1,575.6 |
| HF | OrbiMed New Horizons Master Fund LP | [2020-08-21] | 60.2 | 115.2 |
| Other | OrbiMed Asia Partners IV LP | [2020-05-22] | 0.0 | 837.8 |
| HF | OrbiMed Genesis Master Fund LP | [2020-02-05] | 265.4 | 416.0 |
| PE | OrbiMed Royalty & Credit Opportunities III LP | [2019-05-23] | 889.8 | 1,160.9 |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 33 | 18.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 33 | 18.3 |
| By Discretionary | ||
| Discretionary | 33 | 18.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 33 | 18.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 9.0 | |
| United States Persons | 9.3 | |
| Total | 33 | 18.3 |
| Limited Partners | 2011 - 2023 |
|---|---|
| California State Teachers' Retirement System | |
| Oregon Public Employees Retirement Fund |
| Form D Directors | # Filings | # Firms | 2011 - 2023 | |
|---|---|---|---|---|
| Brian Burkholder | 65 | |||
| John Collis | 89 | |||
| David Wang | 34 | |||
| Jonathan Wang | 39 | |||
| Samuel Isaly | 21 | |||
| Carl Gordon | 98 | |||
| Jonathan Silverstein | 56 | |||
| Peter Thompson | 54 | |||
| David Bonita | 43 | |||
| Sven Borho | 23 | |||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2023 |
|---|---|---|
| 13F-HR | [0001055951] | |
| 3 | [0001055951] | |
| 4 | [0001055951] | |
| SC 13D | [0001055951] | |
| SC 13G | [0001055951] | |
| 3 | [0001491569] | |
| 4 | [0001491569] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
First Eagle Alternative Credit LLC
✚
|
MA | 19.8 |
|
Alcentra Limited
✚
|
19.6 | |
|
Audax Management Company NY LLC
✚
|
NY | 19.5 |
|
Third Point LLC
✚
|
NY | 18.0 |
|
Strategic Value Partners LLC
✚
|
CT | 17.6 |
|
Owl Rock Capital Private Fund Advisors LLC
✚
|
NY | 17.0 |
|
3G Capital Partners LP
✚
|
NY | 17.0 |
|
Alcentra NY LLC
✚
|
NY | 16.8 |
|
Assured Investment Management LLC
✚
|
NY | 16.7 |
|
Omers Infrastructure US Limited
✚
|
NY | 16.7 |